Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Clin Chim Acta. 2020 Sep 12;510:767–771. doi: 10.1016/j.cca.2020.08.039

Table 3.

ST2 TIA and ST2 ELISA predicting 1-year mortality as a dichotomous variable (> 35 vs not)

ST2 TIA ST2 ELISA

Model HR (95% CI) P value HR (95% CI) P value
ST2 4.46 (2.40, 8.31) <0.001 3.50 (1.85, 6.60) <0.001

ST2 2.80 (1.46, 5.40) 0.002 2.49 (1.29, 4.79) 0.006
MAGGIC 1.11 (1.06, 1.16) <0.001 1.12 (1.07, 1.17) <0.001

ST2 2.02 (1.03, 3.96) 0.040 1.87 (0.96, 3.63) 0.066
MAGGIC 1.06 (1.01, 1.11) 0.01 1.07 (1.02, 1.12) 0.007
NTproBNP 1.83 (1.41, 2.38) <0.001 1.86 (1.44, 2.41) <0.001

NTproBNP HR is per 400 ng/L difference in value. ELISA, enzyme-linked immunosorbent assay; HR, hazard ratio; MAGGIC, Meta-analysis Global Group in Chronic Heart Failure; NTproBNP, N-terminal pro b-type natriuretic peptide; P, p-value; TIA, turbidimetric immunoassay; sST2, soluble suppression tumorigenicity 2